Rosie Gilliver is a Clinical Nurse Consultant in Clincal Development and Research at the Kirketon Road Centre, a primary health care facility in Kings Cross, Sydney

Jason has a BSc in Biochemistry and Molecular Biology and a PhD in Pharmacology and Therapeutics, both from the University of British Columbia in Vancouver, Canada. He completed a Postdoctoral Fellowship in Clinical Epidemiology at UNSW in Sydney, Australia. Jason is also a NHMRC Council Career Development Fellow.

Sharon Hutchinson -Sharon Hutchinson is a Professor of Epidemiology and Population Health at Glasgow Caledonian University and holds an honorary appointment at Health Protection Scotland. She has over 20 years experience in conducting epidemiological research to inform on the design and impact of public health interventions. Authoring over 180 publications and PI/co-I on grants worth over £15 million, she leads a broad translational research programme on the prevention, diagnosis, and treatment of hepatitis C (HCV) and other blood-borne viruses. Her research provided the key evidence to guide a public health response to HCV in Scotland, which culminated in Scottish Government investing significantly in their Action Plan (£100 million during 2008-15). The evidenced-based National Plan was the stimulus for WHO and the World Hepatitis Alliance staging their inaugural World Hepatitis Summit (involving governments and civil society representatives from over 80 countries) in Glasgow during 2015.

Professor Dore is Head, Viral Hepatitis Clinical Research Program, Kirby Institute, UNSW Sydney, and Infectious Diseases Physician, St Vincent’s Hospital, Sydney, Australia. He has been involved in viral hepatitis and HIV epidemiological and clinical research, clinical care and public health policy for 20 years. He has developed extensive national and international collaborations, and is internationally recognized in the areas of HCV natural history and epidemiology, therapeutic strategies for acute and chronic HCV infection, particularly among people who inject drugs, and HCV elimination strategies.

Giten Khwairakpam - Giten is currently the Community and Policy Program Manager at amfAR’s TREAT Asia program in Bangkok, Thailand. He is a member of World Health Organization’s Global Guidelines Development Group on hepatitis B and hepatitis C and a member of the Expert Advisory group on HCV with the Medicines Patent Pool. He also has served in different technical groups on viral hepatitis in WHO WPRO and SEARO region. He has been working on improving hepatitis C treatment access and advocating for price reductions in South and South East Asia in partnership with regional and national community networks. He was also profiled as a Change Maker for hepatitis C by the Economist Intelligence Unit in 2016.

Dee Lee - Director and founder of Inno Community Development Organisation, an Nonprofit that aims at creating social impact through social innovation pursuing a dream of a healthy and just society. Inno created the largest and one of most influential Fight Hepatitis Discrimination Programme in Asia which helped 238 factories to remove the job screening of people with hepatitis. In 2009 Inno worked together with hundreds of millions of people to start the hepatitis self-support network in China. Inno is awarded by domestic and international entities in social innovation and philanthropy area.